Avinger, Inc. (AVGR)
NASDAQ: AVGR · Real-Time Price · USD
0.790
+0.010 (1.28%)
Nov 4, 2024, 4:00 PM EST - Market closed

Avinger Revenue

Avinger had revenue of $1.85M in the quarter ending June 30, 2024, a decrease of -9.51%. This brings the company's revenue in the last twelve months to $7.43M, down -9.20% year-over-year. In the year 2023, Avinger had annual revenue of $7.65M, down -7.51%.

Revenue (ttm)
$7.43M
Revenue Growth
-9.20%
P/S Ratio
0.20
Revenue / Employee
$103,181
Employees
72
Market Cap
1.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.65M-621.00K-7.51%
Dec 31, 20228.27M-1.86M-18.33%
Dec 31, 202110.13M1.37M15.63%
Dec 31, 20208.76M-370.00K-4.05%
Dec 31, 20199.13M1.22M15.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
cbdMD 20.64M
Tenon Medical 3.37M
SCWorx 3.37M
Akanda 2.51M
China SXT Pharmaceuticals 1.93M
Helius Medical Technologies 594.00K
60 Degrees Pharmaceuticals 441.26K
FOXO Technologies 155.00K
Revenue Rankings